Literature DB >> 207531

Adaptation of murine MOPC-315 myeloma cells to growth in vitro and further characterization of their C-type viruses.

A Yaniv, A Gazit, M Dvir, D Guthmann, E Eylan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 207531     DOI： 10.1016/0014-2964(78)90008-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Molecular evidence for a type C retrovirus etiology of the lymphoproliferative disease of turkeys.

Authors:  A Gazit; A Yaniv; M Ianconescu; K Perk; B Aizenberg; A Zimber
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Type C virus and immunoglobulin A production by murine myeloma MOPC-315: two independent activities.

Authors:  A Gazit; A Yaniv; D Halperin; S Ben-Efraim
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

3.  The difference between 5-fluorouracil and melphalan in their ability to promote antitumor immune response against MOPC-315 plasmacytoma.

Authors:  S Ben-Efraim; S Shoval; R Ophir
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  RNA-dependent DNA polymerase of an endogenous type C virus of mice: purification and partial characterization.

Authors:  A Hizi; A Yaniv
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

5.  Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil in mice bearing MOPC-315 plasmacytomas.

Authors:  S Ben-Efraim; S Shoval; E de Clercq
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.